Enhanced cocaine responsiveness and impared motor coordination in metabotropic glutamate receptor subtype 2 knockout mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 11, 2005, Pages 4170-4175

  Morishima, Yosuke ^a   Miyakawa, Tsuyoshi ^a   Furuyashiki, Tomoyuki ^a   Tanaka, Yasuhiro ^a   Mizuma, Hiroshi ^b   Nakanishi, Shigetada ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Addiction; Glutamatergic transmission; Hyperactivity; Microdialysis; Nucleus accumbens

Indexed keywords

COCAINE; DOPAMINE; GLUTAMIC ACID; METABOTROPIC RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; CONTROLLED STUDY; FORCED SWIMMING TEST; LOCOMOTION; MICRODIALYSIS; MOTOR COORDINATION; MOUSE; NERVE CELL NETWORK; NONHUMAN; NUCLEUS ACCUMBENS; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BEHAVIOR, ADDICTIVE; COCAINE; DOPAMINE; GLUTAMIC ACID; LOCOMOTION; MICE; MICE, KNOCKOUT; MOTOR SKILLS; NUCLEUS ACCUMBENS; RECEPTORS, METABOTROPIC GLUTAMATE; TIME FACTORS;

EID: 15244356054     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0500914102     Document Type: Article

References (58)

1. Meldrum, B. S. (2000) J. Nutr. 130, 1007S-1015S.
2. Nakanishi, S. (1992) Science 258, 597-603.
3. Conn, P. J. & Pin, J. P. (1997) Annu. Rev. Pharmacol. Toxicol. 37, 205-237.
4. Anwyl, R. (1999) Brain Res. Brain Res. Rev. 29, 83-120.
5. Schoepp, D. D. (2001) J. Pharmacol. Exp. Ther. 299, 12-20.
6. Pizzi, M., Consolandi, O., Memo, M. & Spano, P. F. (1996) Eur. J. Neurosci. 8, 1516-1521.
7. Rouse, S. T., Marino, M. J., Bradley, S. R., Awad, H., Wittmann, M. & Conn, P. J. (2000) Pharmacol. Ther. 88, 427-435.
8. Helton, D. R., Tizzano, J. P., Monn, J. A., Schoepp, D. D. & Kallman, M. J. (1998) J. Pharmacol. Exp. Ther. 284, 651-660.
9. Moghaddam, B. & Adams, B. W. (1998) Science 281, 1349-1352.
10. Kim, J. H. & Vezina, P. (2002) Pharmacol. Biochem. Behav. 73, 333-337.
11. Neki, A., Ohishi, H., Kaneko, T., Shigemoto, R., Nakanishi, S. & Mizuno, N. (1996) Neurosci. Lett. 202, 197-200.
12. Ohishi, H., Neki, A. & Mizuno, N. (1998) Neurosci. Res. 30, 65-82.
13. Tamaru, Y., Nomura, S., Mizuno, N. & Shigemoto, R. (2001) Neuroscience 106, 481-503.
14. Kaneko, S., Hikida, T., Watanabe, D., Ichinose, H., Nagatsu, T., Kreitman, R. J., Pastan, I. & Nakanishi, S. (2000) Science 289, 633-637.
15. Yoshida, K., Watanabe, D., Ishikane, H., Tachibana, M., Pastan, I. & Nakanishi, S. (2001) Neuron 30, 771-780.
16. Watanabe, D. & Nakanishi, S. (2003) Neuron 39, 821-829.
17. Yokoi, M., Kobayashi, K., Manabe, T., Takahashi, T., Sakaguchi, I., Katsuura, G., Shigemoto, R., Ohishi, H., Nomura, S., Nakamura, K., et al. (1996) Science 273, 645-647.
18. Miyakawa, T., Leiter, L. M., Gerber, D. J., Gainetdinov, R. R., Sotnikova, T. D., Zeng, H., Caron, M. G. & Tonegawa, S. (2003) Proc. Natl. Acad. Sci. USA 100, 8987-8992.
19. Porsolt, R. D., Le Pichon, M. & Jalfre, M. (1977) Nature 266, 730-732.
20. Miyakawa, T., Yamada, M., Duttaroy, A. & Wess, J. (2001) J. Neurosci. 21, 5239-5250.
21. Steru, L., Chermat, R., Thierry, B. & Simon, P. (1985) Psychopharmacology 85, 367-370.
22. Hikida, T., Kaneko, S., Isobe, T., Kitabatake, Y., Watanabe, D., Pastan, I. & Nakanishi, S. (2001) Proc. Natl. Acad. Sci. USA 98, 13351-13354.
23. Hikida, T., Kitabatake, Y., Pastan, I. & Nakanishi, S. (2003) Proc. Natl. Acad. Sci. USA 100, 6169-6173.
24. Franklin, K. B. J. & Paxinos, G. (1997) The Mouse Brain in Stereotaxic Coordinates (Academic, San Diego).
25. Mizuma, H., Mizutani, M., Nozaki, S., Iizuka, H., Tohyama, H., Nishimura, N., Watanabe, Y. & Kohashi, R. (2003) Biochem. Biophys. Res. Commun. 302, 156-161.
26. Ito, M. (1984) The Cerebellum and Neural Control (Raven, New York).
27. Mitchell, S. J. & Silver, R. A. (2000) Nature 404, 498-502.
28. Nakanishi, S. (2005) Trends Neurosci. 28, 93-100.
29. Freed, W. J. (1994) Neurosci. Biobehav. Rev. 18, 111-120.
30. Di Chiara, G., Morelli, M. & Consolo, S. (1994) Trends Neurosci. 17, 228-233.
31. Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M. & Carlsson, M. L. (2001) Annu. Rev. Pharmacol. Toxicol. 41, 237-260.
32. Berke, J. D. & Hyman, S. E. (2000) Neuron 25, 515-532.
33. Nestler, E. J. (2001) Nat. Rev. Neurosci. 2, 119-128.
34. Mohn, A. R., Yao, W. D. & Caron, M. G. (2004) Neuropharmacology 47, Suppl. 1, 101-110.
35. Kim, J. H., Beeler, J. A. & Vezina, P. (2000) Neuropharmacology 39, 1692-1699.
36. Breysse, N., Risterucci, C. & Amalric, M. (2002) Pharmacol. Biochem. Behav. 73, 347-357.
37. David, H. N. & Abraini, J. H. (2003) Neuropharmacology 44, 717-727.
38. Tzschentke, T. M. (1998) Prog. Neurobiol. 56, 613-672.
39. Bardo, M. T. & Bevins, R. A. (2000) Psychopharmacology 153, 31-43.
40. Di Chiara, G. & Imperato, A. (1988) Proc. Natl. Acad. Sci. USA 85, 5274-5278.
41. Reid, M. S., Hsu, K., Jr., & Berger, S. P. (1997) Synapse 27, 95-105.
42. Ohishi, H., Shigemoto, R., Nakanishi, S. & Mizuno, N. (1993) Neuroscience 53, 1009-1018.
43. Sesack, S. R., Carr, D. B., Omelchenko, N. & Pinto, A. (2003) Ann. N.Y. Acad. Sci. 1003, 36-52.
44. Kenny, P. J. & Markou, A. (2004) Trends Pharmacol. Sci. 25, 265-272.
45. Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S., Corsi, M., Orzi, F. & Conquet, F. (2001) Nat. Neurosci. 4, 873-874.
46. David, H. N. & Abraini, J. H. (2001) Neuropharmacology 41, 454-463.
47. O'Neill, M. F., Heron-Maxwell, C., Conway, M. W., Monn, J. A. & Ornstein, P. (2003) Neuropharmacology 45, 565-574.
48. Swanson, C. J. & Kalivas, P. W. (2000) J. Pharmacol. Exp. Ther. 292, 406-414.
49. Renard, C. E., Dailly, E., David, D. J., Hascoet, M. & Bourin, M. (2003) Fundam. Clin. Pharmacol. 17, 449-455.
50. Pliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J. & Carlezon, W. A., Jr. (2001) J. Neurosci. 21, 7397-7403.
51. Middleton, F. A. & Strick, P. L. (2000) Brain Res. Brain Res. Rev. 31, 236-250.
52. Hu, G., Duffy, P., Swanson, C., Ghasemzadeh, M. B. & Kalivas, P. W. (1999) J. Pharmacol. Exp. Ther. 289, 412-416.
53. Xi, Z. X., Baker, D. A., Shen, H., Carson, D. S. & Kalivas, P. W. (2002) J. Pharmacol. Exp. Ther. 300, 162-171.
54. Otani, S., Daniel, H., Takita, M. & Crepel, F. (2002) J. Neurosci. 22, 3434-3444.
55. Robbe, D., Alonso, G., Chaumont, S., Bockaert, J. & Manzoni, O. J. (2002) J. Neurosci. 22, 4346-4356.
56. Lorrain, D. S., Baccei, C. S., Bristow, L. J., Anderson, J. J. & Varney, M. A. (2003) Neuroscience 117, 697-706.
57. Krebs, M. O., Desce, J. M., Kernel, M. L., Gauchy, C., Godeheu, G., Cheramy, A. & Glowinski, J. (1991) J. Neurochem. 56, 81-85.
58. Desce, J. M., Godeheu, G., Galli, T., Artaud, F., Cheramy, A. & Glowinski, J. (1992) Neuroscience 47, 333-339.